Durable donor engraftment after radioimmunotherapy using  -emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation

Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases

(2011) A. S. Schulz et al.   BLOOD

RBE of α-particles from211At for complex DNA damage and cell survival in relation to cell cycle position

(2010) Kristina Claesson et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Non-malignant Thyroid Diseases after a Wide Range of Radiation Exposures

(2010) Elaine Ron et al.   RADIATION RESEARCH

Cancer Therapy with Alpha-Emitters Labeled Peptides

(2010) Ekaterina Dadachova   SEMINARS IN NUCLEAR MEDICINE

The canine major histocompatibility complex

(2010) Robert F. Raff et al.   TISSUE ANTIGENS

Pilot Study of a 213Bismuth-Labeled Anti-CD45 mAb as a Novel Nonmyeloablative Conditioning for DLA-Haploidentical Littermate Hematopoietic Transplantation

(2010) Hirohisa Nakamae et al.   TRANSPLANTATION

Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome

(2009) J. M. Pagel et al.   BLOOD

Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the  -Emitting Radionuclides Bismuth-213 or Astatine-211

(2009) H. Nakamae et al.   CANCER RESEARCH

Bone Marrow Progenitor Cells Repair Rat Hepatic Sinusoidal Endothelial Cells After Liver Injury

(2009) Rula Harb et al.   GASTROENTEROLOGY